Skip to search formSkip to main contentSkip to account menu

Pneumovax 23

Known as: PPSV23 
National Institutes of Health

Related topics

Related topics

13 relations

Broader (13)

23-valent pneumococcal capsular polysaccharide vaccinePolyvalent pneumococcal vaccinepneumococcal capsular polysaccharide type 10A vaccinepneumococcal capsular polysaccharide type 11A vaccine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Correlation between family physician’s direct advice and pneumococcal vaccination intention and behavior among the elderly in Japan: a cross-sectional study
BackgroundVaccination is an important element of health maintenance in family medicine. The 23-valent pneumococcal polysaccharide… 
2017
2017
The distribution and annual changes in the Streptococcus pneumoniae serotypes in adult Japanese patients with pneumococcal pneumonia from 2011 to 2015.
Highly Cited
2016
Highly Cited
2016
Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept
BackgroundPatients with rheumatoid arthritis (RA), including those treated with biologics, are at increased risk of some vaccine… 
2016
2016
Immunogenicity of pneumococcal polysaccharide vaccine in adult systemic lupus erythematosus patients undergoing immunosuppressive treatment
Objective To evaluate the immunogenicity of the 23-valent pneumococcal polysaccharide vaccine (PPSV23) in adult systemic lupus… 
2015
2015
13‐valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6‐17 years of age with sickle cell disease previously vaccinated with 23‐valent pneumococcal polysaccharide…
A large population of older children with sickle cell disease (SCD) is currently vaccinated with only 23‐valent pneumococcal… 
Highly Cited
2015
Highly Cited
2015
Serotype Changes and Drug Resistance in Invasive Pneumococcal Diseases in Adults after Vaccinations in Children, Japan, 2010–2013
Pneumococcal conjugate vaccination of children is associated with penicillin-resistant Streptococcus pneumoniae in adults. 
2015
2015
Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine compared to the 23-valent pneumococcal polysaccharide vaccine in elderly Japanese adults
Streptococcus pneumoniae is a major cause of severe disease worldwide, particularly in the elderly population. Due to increasing… 
Highly Cited
2014
Highly Cited
2014
Patients with Crohn's disease on anti-tumor necrosis factor therapy are at significant risk of inadequate response to the 23-valent pneumococcal polysaccharide vaccine.
2013
2013
Cost-Effectiveness of Pneumococcal Vaccines for Adults in the United States
IntroductionIn 2012, the Advisory Committee on Immunization Practices (ACIP) revised recommendations for adult pneumococcal… 
Highly Cited
2009
Highly Cited
2009
Superior immune response to protein-conjugate versus free pneumococcal polysaccharide vaccine in chronic obstructive pulmonary disease.
RATIONALE Debate exists about the immunogenicity and protective efficacy of antibodies produced by the 23-valent pneumococcal… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)